New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
10:00 EDTFCX, SNBC, MON, AYI, SPLK, OPEN, INTC, EEP, WSH, NFX, LLYOn The Fly: Analyst Upgrade Summary
Acuity Brands (AYI) upgraded to Buy from Hold at Canaccord... Eli Lilly (LLY) upgraded to Outperform from Market Perform at Cowen... Intel (INTC) upgraded to Overweight from Neutral at Piper Jaffray... Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan... Newfield Exploration (NFX) upgraded to Buy from Neutral at UBS... OpenTable (OPEN) upgraded to Buy from Neutral at Citigroup... Sun Bancorp (SNBC) upgraded to Neutral from Underperform at Sterne Agee... Willis Group (WSH) upgraded to Buy from Neutral at Nomura... Splunk (SPLK) upgraded to Outperform from Underperform at CLSA... Freeport McMoRan (FCX) upgraded to Outperform from Neutral at Macquarie... Enbridge Energy (EEP) upgraded at Credit Suisse.
News For AYI;LLY;INTC;MON;NFX;OPEN;SNBC;WSH;SPLK;FCX;EEP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
November 20, 2014
11:52 EDTINTCIntel CEO confirms organizational change made this week
The Wall Street Journal reported earlier this week that Intel has reorganized by combing its groups that handle personal computer chips with those used for smartphones and tablets, and Intel CEO Brian Krzanich confirmed the change during the company's investor day presentation.
11:32 EDTINTCIntel says high-end gaming segment among fastest growing in PCs
Subscribe for More Information
09:51 EDTSPLKSplunk likely to continue 'big beat, small raise' pattern, says Janney Capital
Subscribe for More Information
November 19, 2014
10:29 EDTINTCGoogle now top competitor to Apple, Jefferies says
Subscribe for More Information
09:01 EDTSPLKBig data for security could reach $4B-$5B, says FBR Capital
Subscribe for More Information
08:33 EDTSPLKSplunk November volatility elevated into Q3 and outlook
Splunk November call option implied volatility is at 126, December is at 65, January is at 57; compared to it 26-week average of 56 according to Track Data, suggesting large price movement into the expected release of Q3 on November 20.
November 18, 2014
11:50 EDTINTCIntel November volatility elevated into investor meeting
Subscribe for More Information
10:55 EDTINTCIntel to host investor meeting
Investor meeting to be held in Santa Clara, CA on November 20 at 11 am. Webcast Link
09:56 EDTFCXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:06 EDTINTCIntel to combine two groups in new 'Client Computing' unit, WSJ says
Intel plans to reorganize by combing its groups that handle personal computer chips with those used for smartphones and tablets, according to The Wall Street Journal, citing an email sent to employees by CEO Brian Krzanich. Intelís changes are scheduled to go into effect in early 2015, the report noted. Reference Link
06:33 EDTFCXFreeport McMoRan initiated with a Market Perform at BMO Capital
Subscribe for More Information
06:08 EDTINTCIntel's 'Mica' bracelet to feature Google alerts, AT&T data plan, Re/code says
Subscribe for More Information
November 17, 2014
16:04 EDTLLYEli Lilly says empagliflozin tablets reduced A1C, body weight and abdominal fat
Empagliflozin tablets reduced hemoglobin A1C (a measure of average blood sugar over the past two to three months), body weight and several markers of abdominal fat in adults with type 2 diabetes, according to a new retrospective analysis of clinical trial data presented on behalf of Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company at the 2014 Scientific Sessions of the American Heart Association in Chicago. Abdominal fat, also known as visceral fat, sits on or near vital organs. The study presented at AHA included analyses of two sets of adults with T2D treated with either empagliflozin or placebo. The first group consisted of 823 adults with high blood pressure who were treated for 12 weeks, while the second examined a pool of 2,476 adults from four different trials who were treated for 24 weeks. These randomized studies compared empagliflozin with placebo as an add-on to existing therapy, including metformin, metformin plus sulfonylurea, or pioglitazone with or without metformin. In both groups, treatment with empagliflozin significantly reduced A1C, body weight and several markers of abdominal fat compared with placebo. Changes in estimated total body fat did not reach statistical significance.
11:44 EDTNFXStocks with call strike movement; YHOO NFX
Yahoo (YHOO) February 60 call option implied volatility increased 4% to 39, Newfield Exploration (NFX) March 38 call option implied volatility increased 9% to 40 according to IVolatility.
11:06 EDTLLYLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
07:52 EDTINTCDepartment of Energy awards $425M for supercomputing technologies
Subscribe for More Information
November 14, 2014
17:27 EDTFCXPaulson & Co. gives quarterly update on stakes
Subscribe for More Information
14:53 EDTLLYCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
13:38 EDTSPLKSplunk November volatility elevated into Q3 and outlook
Subscribe for More Information
12:53 EDTFCXOmega Advisors gives quarterly update on stakes
NEW STAKES: AerCap Holdings (AER), Nordic American Offshore (NAO), Melco Crown Entertainment (MPEL), Groupon (GRPN), and Ashland (ASH). INCREASED STAKES: QEP Resources (QEP), United Continental (UAL), Cabot Oil & Gas (COG), Actavis (ACT), and KAR Auction Services (KAR). DECREASED STAKES: Sprint (S), SandRidge Energy (SD), Sirius XM Holdings (SIRI), Kinder Morgan (KMI), and Transocean (RIG). LIQUIDATED STAKES: QUALCOMM (QCOM), Ocwen Financial (OCN), Freeport-McMoRan (FCX), Boston Scientific (BSX), and Capital One (COF).
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use